AGE (Shorten Name ),
Human AGE/ Advanced glycation end-product Recombinant Protein
>90% by SDS-PAGE
Please contact the technician for more information.
50mM NaH2PO4, 500mM NaCl Buffer with 500mM Imidazole,10%glycerol(PH8.0)
Store at -20°C. (Avoid repeated freezing and thawing.)
R&D Technical Data
For more information, please refer to the manual,Or contact our technical support: firstname.lastname@example.org.
An advanced glycation end-product (AGE) is the result of a chain of chemical reactions after an initial glycation reaction. The intermediate products are known, variously, as Amadori, Schiff base and Maillard products, named after the researchers who first described them. (The literature is inconsistent in applying these terms. For example, Maillard reaction products are sometimes considered intermediates and sometimes end products.) Side products generated in intermediate steps may be oxidizing agents (such as hydrogen peroxide), or not (such as beta amyloid proteins). "Glycosylation" is sometimes used for "glycation" in the literature, usually as 'non-enzymatic glycosylation.'
"Accumulation of advanced glycation end products (AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes"
M Kopytek, M Ząbczyk, P Mazur, et al.
"Skin autofluorescence is associated with carotid intima-media thickness, diabetic microangiopathy, and long-lasting metabolic control in type 1 ..."
A Aleksandra, N Dariusz, Z Dorota, et al.
From: Microvascular Research
"c-reactive protein, advanced glycation end products, and their receptor in type 2 diabetic, elderly patients with mild cognitive impairment"
Gorska-Ciebiada M, Saryusz-Wolska M, Borkowska A, et al
Displaying results : 0
No feedback yet, let's comment.
Product Name *
Size Quantity Price ($) Subtotal 1 ($)
Subtotal 2: $
Size Quantity Price ($)
Do you want to be our agent and get a lower discount?
Please contact us:
Please contact us: